Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis
Open Access
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 19 (5) , 717-725
- https://doi.org/10.1038/modpathol.3800581
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Chromosome 22q Deletions in Atypical Teratoid/Rhabdoid Tumors in AdultsBrain Pathology, 2006
- INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomasLaboratory Investigation, 2005
- SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid SarcomasCancer Research, 2005
- Immunohistochemical Analysis of hSNF5/INI1 Distinguishes Renal and Extra-renal Malignant Rhabdoid Tumors From Other Pediatric Soft Tissue TumorsThe American Journal of Surgical Pathology, 2004
- Immunohistochemical Analysis of hSNF5/INI1 in Pediatric CNS NeoplasmsThe American Journal of Surgical Pathology, 2004
- Mutational analysis of INI1 in sporadic human brain tumorsActa Neuropathologica, 2001
- Renal medullary carcinoma: Prolonged remission with chemotherapy, immunohistochemical characterisation and evidence of bcr/abl rearrangementMedical and Pediatric Oncology, 1999
- Truncating mutations of hSNF5/INI1 in aggressive paediatric cancerNature, 1998
- Renal medullary carcinoma: Clinical and therapeutic aspects of a newly described tumorCancer, 1996
- Monosomy 22 in rhabdoid or atypical tumors of the brainJournal of Neurosurgery, 1990